| abstract |
At least one for discharging cardioversion or electrical demand pacer pulses or for treating conditions such as cardiac arrest, bradycardia, arrhythmia, cardiac arrest, PEA, EMD and other cardiac conditions Disclosed are methods and devices for delivering pharmaceutical agents. The pharmaceutical agent can be delivered to the heart tissue, heart cavity, or peritoneal cavity. The pharmaceutical agent may also include an analgesic, such as morphine. Pharmaceutical agents used for increasing myocardial contractility or inhibiting platelet aggregation, and vasoactive intestinal polypeptide (VIP) are also included, and thyroid hormones such as T3 and T4 can be delivered. Also encompassed by the invention are methods for treating patients with cardiac arrest or pulmonary hypertension by administering a therapeutically effective amount of a vasoactive intestinal polypeptide. |